(Q34653386)

3 August 2017

title

Randomized controlled crossover trial of ketamine in obsessive-compulsive disorder: proof-of-concept (English)

1 reference

obsessive-compulsive disorder

3 August 2017

main subject

0 references

1

Carolyn I Rodriguez

1 reference

3 August 2017

Lawrence S Kegeles

2

1 reference

3 August 2017

Amanda Levinson

3

1 reference

3 August 2017

Tianshu Feng

4

1 reference

3 August 2017

Sue M Marcus

5

1 reference

3 August 2017

Donna Vermes

6

1 reference

3 August 2017

Pamela Flood

7

1 reference

3 August 2017

Helen B Simpson

8

1 reference

3 August 2017

language of work or name

English

0 references

publication date

19 June 2013

1 reference

3 August 2017

published in

Neuropsychopharmacology

1 reference

3 August 2017

volume

38

1 reference

3 August 2017

issue

12

1 reference

3 August 2017

page(s)

2475-2483

1 reference

A randomized trial of a low-trapping nonselective N-methyl-D-aspartate channel blocker in major depression

3 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3799067

Clinical experience using intranasal ketamine in the treatment of pediatric bipolar disorder/fear of harm phenotype

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3799067

N-acetylcysteine add-on treatment in refractory obsessive-compulsive disorder: a randomized, double-blind, placebo-controlled trial

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3799067

The role of eukaryotic elongation factor 2 kinase in rapid antidepressant action of ketamine

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3799067

Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3799067

Effects of ketamine in treatment-refractory obsessive-compulsive disorder

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3799067

A Randomized, placebo-controlled, crossover pilot trial of the oral selective NR2B antagonist MK-0657 in patients with treatment-resistant major depressive disorder

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3799067

Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3799067

Ketamine effects on brain GABA and glutamate levels with 1H-MRS: relationship to ketamine-induced psychopathology.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3799067

Glutamate abnormalities in obsessive compulsive disorder: neurobiology, pathophysiology, and treatment

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3799067

Lack of effect of ketamine on cortical glutamate and glutamine in healthy volunteers: a proton magnetic resonance spectroscopy study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3799067

Rapid resolution of obsessions after an infusion of intravenous ketamine in a patient with treatment-resistant obsessive-compulsive disorder

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3799067

The antidepressant effect of ketamine is not associated with changes in occipital amino acid neurotransmitter content as measured by [(1)H]-MRS.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3799067

Minocycline augmentation of pharmacotherapy in obsessive-compulsive disorder: an open-label trial

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3799067

mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3799067

A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3799067

Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3799067

A single-blinded case-control study of memantine in severe obsessive-compulsive disorder

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3799067

Memantine augmentation in treatment-resistant obsessive-compulsive disorder: an open-label trial

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3799067

Predicting genetic loading from symptom patterns in obsessive- compulsive disorder: a latent variable analysis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3799067

Further development of YBOCS dimensions in the OCD Collaborative Genetics study: symptoms vs. categories

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3799067

Practice guideline for the treatment of patients with obsessive-compulsive disorder

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3799067

Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3799067

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3799067

A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3799067

Defining response in clinical trials for obsessive-compulsive disorder: a signal detection analysis of the Yale-Brown obsessive compulsive scale.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3799067

Mechanism of action of memantine

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3799067

Riluzole augmentation in treatment-resistant obsessive-compulsive disorder: an open-label trial

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3799067

Practice guideline for the treatment of patients with schizophrenia, second edition.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3799067

A rating scale for depression

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3799067

Pharmacotherapy of obsessive-compulsive disorder in a health maintenance organization.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3799067

Antidepressant effects of ketamine in depressed patients

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3799067

Delayed obsessive-compulsive disorder symptom exacerbation after a single dose of a serotonin antagonist in fluoxetine-treated but not untreated patients

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3799067

Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3799067

Some conceptual and statistical issues in analysis of longitudinal psychiatric data. Application to the NIMH treatment of Depression Collaborative Research Program dataset

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3799067

The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3799067

The Yale-Brown Obsessive Compulsive Scale. II. Validity

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3799067

Comparative anxiogenic, neuroendocrine, and other physiologic effects of m-chlorophenylpiperazine given intravenously or orally to healthy volunteers

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3799067

A rating scale for mania: reliability, validity and sensitivity

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3799067

Acute changes in obsessions and compulsions following moderate-intensity aerobic exercise among patients with obsessive-compulsive disorder.

7 July 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2013.150

Association of a glutamate (NMDA) subunit receptor gene (GRIN2B) with obsessive-compulsive disorder: a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2013.150

Glutamate transporter gene SLC1A1 associated with obsessive-compulsive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2013.150

Anti-brain autoantibodies and altered excitatory neurotransmitters in obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2013.150

Sapap3 and pathological grooming in humans: Results from the OCD collaborative genetics study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2013.150

Glutamatergic dysfunction in OCD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2013.150

Memantine add-on in moderate to severe obsessive-compulsive disorder: randomized double-blind placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2013.150

N-acetylcysteine augmentation in serotonin reuptake inhibitor refractory obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2013.150

Discovering the neural basis of human social anxiety: a diagnostic and therapeutic imperative

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2013.150

Reduced anterior cingulate glutamatergic concentrations in childhood OCD and major depression versus healthy controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2013.150

Effects of ketamine on anterior cingulate glutamate metabolism in healthy humans: a 4-T proton MRS study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2013.150

A family-based association study of the glutamate transporter gene SLC1A1 in obsessive-compulsive disorder in 378 families

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2013.150

Association of the SLC1A1 glutamate transporter gene and obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2013.150

A screen of SLC1A1 for OCD-related alleles.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3799067

Differential efficacy of memantine for obsessive-compulsive disorder vs. generalized anxiety disorder: an open-label trial.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3799067

Treatment of obsessive-compulsive disorder by U.S. psychiatrists.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3799067

Patterns of remission and relapse in obsessive-compulsive disorder: a 2-year prospective study.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3799067

Association Testing of the Positional and Functional Candidate Gene SLC1A1/EAAC1 in Early-Onset Obsessive-compulsive Disorder

26 October 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2013.150

Measurement of dissociative states with the Clinician-Administered Dissociative States Scale (CADSS)

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23783065

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Glutamatergic drugs exacerbate symptomatic behavior in a transgenic model of comorbid Tourette's syndrome and obsessive-compulsive disorder

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23783065

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Decrease in caudate glutamatergic concentrations in pediatric obsessive-compulsive disorder patients taking paroxetine

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23783065

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NPP.2013.150

1 reference

Dimensions Publication ID

3 August 2017

0 references

1 reference

3 August 2017

1 reference